Rheumatoid lung disease with rheumatoid arthritis of hand
ICD-10 M05.14 is a billable code used to indicate a diagnosis of rheumatoid lung disease with rheumatoid arthritis of hand.
Rheumatoid lung disease is a serious complication of rheumatoid arthritis (RA), characterized by interstitial lung disease, pleural effusions, and pulmonary nodules. Anatomically, the lungs are affected by the systemic inflammatory process of RA, leading to fibrosis and impaired gas exchange. Clinically, patients may present with dyspnea, cough, and reduced exercise tolerance. The involvement of the hands in RA typically manifests as symmetrical polyarthritis, affecting the metacarpophalangeal and proximal interphalangeal joints, leading to deformities such as ulnar deviation and swan-neck deformities. The combination of lung disease and hand involvement complicates the clinical picture, necessitating a multidisciplinary approach to management, including rheumatologic and pulmonary evaluations.
Orthopedic documentation should include imaging studies (X-rays, MRIs) to assess joint damage and functional assessments to evaluate range of motion and strength.
Patients may require surgical intervention for severe joint deformities or instability, such as arthroplasties or tendon repairs.
Documentation must detail the specific joints involved, the extent of damage, and any functional limitations.
Rheumatologic documentation should include laboratory tests for inflammatory markers (e.g., ESR, CRP) and assessments of disease activity (e.g., DAS28 score).
Management of RA may involve DMARDs, biologics, and monitoring for lung complications.
Systemic involvement must be documented, including any pulmonary function tests and imaging findings.
Functional assessments should evaluate mobility, strength, and the need for assistive devices.
Rehabilitation may focus on improving joint function and respiratory therapy for lung involvement.
Mobility limitations due to joint pain and lung disease must be clearly documented to justify therapy.
Used for follow-up visits assessing both joint and lung involvement.
Documentation must include history, examination findings, and management plans for both RA and lung disease.
Rheumatology and pulmonology considerations for comprehensive care.
Key documentation includes detailed descriptions of joint involvement, evidence of lung disease (such as imaging or pulmonary function tests), and any systemic symptoms. It is essential to document the severity and impact on function.
